These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16717037

  • 21. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
    Kapetanovic IM, Horn TL, Johnson WD, Cwik MJ, Detrisac CJ, McCormick DL.
    Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
    [Abstract] [Full Text] [Related]

  • 22. LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model.
    Dorward AM, Shultz KL, Beamer WG.
    Endocr Relat Cancer; 2007 Jun; 14(2):369-79. PubMed ID: 17639051
    [Abstract] [Full Text] [Related]

  • 23. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice.
    Hu Y, Le Leu RK, Belobrajdic D, Young GP.
    Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of chemopreventive agents for genotoxic activity.
    Doppalapudi RS, Riccio ES, Rausch LL, Shimon JA, Lee PS, Mortelmans KE, Kapetanovic IM, Crowell JA, Mirsalis JC.
    Mutat Res; 2007 May 18; 629(2):148-60. PubMed ID: 17387038
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.
    Torrey CE, Campbell JA, Hoivik DJ, Miller RT, Allen JS, Mann PC, Selinger K, Rickert D, Savina PM, Santostefano MJ.
    Int J Toxicol; 2005 May 18; 24(5):289-99. PubMed ID: 16257849
    [Abstract] [Full Text] [Related]

  • 26. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice.
    Arbogast S, Smith J, Matuszczak Y, Hardin BJ, Moylan JS, Smith JD, Ware J, Kennedy AR, Reid MB.
    J Appl Physiol (1985); 2007 Mar 18; 102(3):956-64. PubMed ID: 17110517
    [Abstract] [Full Text] [Related]

  • 27. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
    Chiesa G, Rigamonti E, Lovati MR, Disconzi E, Soldati S, Sacco MG, Catò EM, Patton V, Scanziani E, Vezzoni P, Arnoldi A, Locati D, Sirtori CR.
    Mol Nutr Food Res; 2008 Oct 18; 52(10):1121-9. PubMed ID: 18655005
    [Abstract] [Full Text] [Related]

  • 28. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 18; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 29. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
    Hursting SD, Perkins SN, Haines DC, Ward JM, Phang JM.
    Cancer Res; 1995 Sep 15; 55(18):3949-53. PubMed ID: 7664260
    [Abstract] [Full Text] [Related]

  • 30. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
    Manjanatha MG, Shelton S, Bishop ME, Lyn-Cook LE, Aidoo A.
    Carcinogenesis; 2006 Dec 15; 27(12):2555-64. PubMed ID: 17127718
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC).
    Witschi H, Espiritu I.
    Cancer Lett; 2002 Sep 26; 183(2):141-6. PubMed ID: 12065088
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Soy, isoflavones, and prostate cancer.
    Jian L.
    Mol Nutr Food Res; 2009 Feb 26; 53(2):217-26. PubMed ID: 18985655
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein.
    Huang ZR, Hung CF, Lin YK, Fang JY.
    Int J Pharm; 2008 Nov 19; 364(1):36-44. PubMed ID: 18761396
    [Abstract] [Full Text] [Related]

  • 38. Soy isoflavone genistein in prevention and treatment of prostate cancer.
    Perabo FG, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ.
    Prostate Cancer Prostatic Dis; 2008 Nov 19; 11(1):6-12. PubMed ID: 17923857
    [Abstract] [Full Text] [Related]

  • 39. Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages.
    Dia VP, Berhow MA, Gonzalez De Mejia E.
    J Agric Food Chem; 2008 Dec 24; 56(24):11707-17. PubMed ID: 19053380
    [Abstract] [Full Text] [Related]

  • 40. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
    Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M.
    Carcinogenesis; 2007 Nov 24; 28(11):2398-403. PubMed ID: 17602169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.